Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arka De

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Clinical Liver Disease|October 25, 2021
Nonalcoholic Fatty Liver Disease: Indian PerspectiveArka De, Ajay Duseja
Journal of Clinical and Experimental Hepatology|May 15, 2020
Natural History of Simple Steatosis or Nonalcoholic Fatty LiverArka De, Ajay Duseja
The National Medical Journal of India|February 3, 2022
Future pharmacotherapy for non-alcoholic steatohepatitisArka DE Ajay Duseja
Alimentary Pharmacology & Therapeutics|March 11, 2024
Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease-authors' replyNipun Verma, Arka De, Ajay Duseja
Gastroenterology Clinics of North America|January 25, 2026
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver DiseaseArka De, Naga Chalasani, Ajay Duseja
The Permanente Journal|April 14, 2017
Image Diagnosis: Unusual Cause of Gastrointestinal Bleeding in a Young Man: Isolated Gastric AngiodysplasiasSandeep Lamoria, Arka De, Vishal Sharma
Clinics in Liver Disease|April 6, 2023
Special Population: Lean Nonalcoholic Fatty Liver DiseaseAjay Duseja, Arka De, Vincent Wong
Journal of Hepatology|June 17, 2020
Transition of AKI to CKD in cirrhosis - effect of baseline eGFR and unanswered questionsInderbhan Singh, Arka De, Virendra Singh
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?Rohit Mehtani, Arka De, Virendra Singh
Journal of Hepatology|May 27, 2024
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohortArka De, Manu Mehta, Ajay Duseja, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Clinical Liver Disease|October 25, 2021
Nonalcoholic Fatty Liver Disease: Indian PerspectiveArka De, Ajay Duseja
Journal of Clinical and Experimental Hepatology|May 15, 2020
Natural History of Simple Steatosis or Nonalcoholic Fatty LiverArka De, Ajay Duseja
The National Medical Journal of India|February 3, 2022
Future pharmacotherapy for non-alcoholic steatohepatitisArka DE Ajay Duseja
Alimentary Pharmacology & Therapeutics|March 11, 2024
Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease-authors' replyNipun Verma, Arka De, Ajay Duseja
Gastroenterology Clinics of North America|January 25, 2026
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver DiseaseArka De, Naga Chalasani, Ajay Duseja
The Permanente Journal|April 14, 2017
Image Diagnosis: Unusual Cause of Gastrointestinal Bleeding in a Young Man: Isolated Gastric AngiodysplasiasSandeep Lamoria, Arka De, Vishal Sharma
Clinics in Liver Disease|April 6, 2023
Special Population: Lean Nonalcoholic Fatty Liver DiseaseAjay Duseja, Arka De, Vincent Wong
Journal of Hepatology|June 17, 2020
Transition of AKI to CKD in cirrhosis - effect of baseline eGFR and unanswered questionsInderbhan Singh, Arka De, Virendra Singh
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?Rohit Mehtani, Arka De, Virendra Singh
Journal of Hepatology|May 27, 2024
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohortArka De, Manu Mehta, Ajay Duseja, et al.
Pageof 15